ChemicalBook > Product Catalog >Analytical Chemistry >Standard >Pharmaceutical Impurity Reference Standards >N-(4-(2-Methyl-5,6-dihydro-4H-benzo[b]oxazolo[5,4-d]azepine-6-carbonyl)phenyl)-[1,1'-biphenyl]-2-carboxaMide
N-(4-(2-Methyl-5,6-dihydro-4H-benzo[b]oxazolo[5,4-d]azepine-6-carbonyl)phenyl)-[1,1'-biphenyl]-2-carboxaMide
![N-(4-(2-Methyl-5,6-dihydro-4H-benzo[b]oxazolo[5,4-d]azepine-6-carbonyl)phenyl)-[1,1'-biphenyl]-2-carboxaMide Structure](CAS/20150408/GIF/168626-93-5.gif)
- CAS No.
- 168626-93-5
- Chemical Name:
- N-(4-(2-Methyl-5,6-dihydro-4H-benzo[b]oxazolo[5,4-d]azepine-6-carbonyl)phenyl)-[1,1'-biphenyl]-2-carboxaMide
- Synonyms
- Conivaptan-7;Conivaptan Impurity 4;Conivaptan impurity G;Conivaptan oxazole byproduct;Conivaptan hydrochkoride Impurity G;Conivaptan hydrochloride Impurity G;N-(4-(2-Methyl-5,6-dihydro-4H-benzo[b]oxazolo[5,4-d]azepine-6-carbonyl)phenyl)-[1,1'-biphenyl]-2-carboxaMide;[1,1'-Biphenyl]-2-carboxamide, N-[4-[(4,5-dihydro-2-methyl-6H-oxazolo[4,5-d][1]benzazepin-6-yl)carbonyl]phenyl]-
- CBNumber:
- CB32681127
- Molecular Formula:
- C32H25N3O3
- Molecular Weight:
- 499.56
- MOL File:
- 168626-93-5.mol
N-(4-(2-Methyl-5,6-dihydro-4H-benzo[b]oxazolo[5,4-d]azepine-6-carbonyl)phenyl)-[1,1'-biphenyl]-2-carboxaMide Preparation Products And Raw materials
Raw materials
Preparation Products
N-(4-(2-Methyl-5,6-dihydro-4H-benzo[b]oxazolo[5,4-d]azepine-6-carbonyl)phenyl)-[1,1'-biphenyl]-2-carboxaMide Suppliers
Global( 26)Suppliers
Supplier | Tel | Country | ProdList | Advantage | Inquiry |
---|---|---|---|---|---|
Pharmaffiliates Analytics and Synthetics P. Ltd | +91-172-5066494 | Haryana, India | 6773 | 58 | Inquiry |
Pharma Affiliates | 172-5066494 | Haryana, India | 6761 | 58 | Inquiry |
Hangzhou MolCore BioPharmatech Co.,Ltd. | +86-057181025280; +8617767106207 | China | 49739 | 58 | Inquiry |
Amadis Chemical Company Limited | 571-89925085 | China | 131980 | 58 | Inquiry |
Shenzhen Polymeri Biochemical Technology Co., Ltd. | +86-400-002-6226 13028896684 | China | 56070 | 58 | Inquiry |
Hubei Moco Chemical Co., Ltd. | 18576690171 | China | 10974 | 58 | Inquiry |
Anhui Feixiang Pharmaceutical Technology Co., Ltd. | 13349001619 | CHINA | 1007 | 58 | Inquiry |
Shanghai Hao Zhun Biological Technology Co., Ltd. | 15800340161 | CHINA | 6846 | 58 | Inquiry |
Guangzhou Dreampharm Biotechnology Co., Ltd. | 020-36607679 17825480238 | China | 9875 | 12 | Inquiry |
Foshan Treasure Biotechnology Co., Ltd | 0757-85921206 18520245316 | China | 12664 | 58 | Inquiry |
168626-93-5(N-(4-(2-Methyl-5,6-dihydro-4H-benzo[b]oxazolo[5,4-d]azepine-6-carbonyl)phenyl)-[1,1'-biphenyl]-2-carboxaMide)Related Search:
N-(4-(2-Methyl-5,6-dihydro-4H-benzo[b]oxazolo[5,4-d]azepine-6-carbonyl)phenyl)-[1,1'-biphenyl]-2-carboxaMide
Conivaptan hydrochloride Impurity G
Conivaptan hydrochkoride Impurity G
Conivaptan Impurity 4
Conivaptan-7
Conivaptan impurity G
[1,1'-Biphenyl]-2-carboxamide, N-[4-[(4,5-dihydro-2-methyl-6H-oxazolo[4,5-d][1]benzazepin-6-yl)carbonyl]phenyl]-
Conivaptan oxazole byproduct
168626-93-5